General Information
Elagolix, sold under the brand name Orilissa, is the first oral gonadotropin-releasing hormone antagonist used to treat endometriosis.
About the API
Systematic name
N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide
Trade name(s)
amorphous
Technology
Synthetic
Therapeutic category
Genitourinary
Available formulations
Oral Solid
Regulations
US DMF
US DMF